London | Britain has taken a big step forward in the global race to defeat COVID-19, announcing breakthroughs in the search for both a vaccine and a more effective treatment.
The partnership between AstraZeneca and Oxford University has confirmed that its initial trials have demonstrated its candidate vaccine is potentially safe and also able to trigger immune responses.
Loading...
Hans van Leeuwen covers British and European politics, economics and business from London. He has worked as a reporter, editor and policy adviser in Sydney, Canberra, Hanoi and London. Connect with Hans on Twitter. Email Hans at hans.vanleeuwen@afr.com
